OptimizeRx Corporation
OPRX
$6.52
$0.091.40%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 23.68% | -10.71% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 23.68% | -10.71% | |||
| Cost of Revenue | -4.82% | -19.02% | |||
| Gross Profit | 37.59% | -6.00% | |||
| SG&A Expenses | -2.09% | 0.10% | |||
| Depreciation & Amortization | -0.19% | 0.56% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.98% | -7.65% | |||
| Operating Income | 335.95% | -35.72% | |||
| Income Before Tax | 612.20% | -38.76% | |||
| Income Tax Expenses | 807.78% | 49.17% | |||
| Earnings from Continuing Operations | 544.42% | -49.15% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 544.42% | -49.15% | |||
| EBIT | 335.95% | -35.72% | |||
| EBITDA | 249.08% | -27.58% | |||
| EPS Basic | 542.00% | -49.40% | |||
| Normalized Basic EPS | 643.63% | -38.93% | |||
| EPS Diluted | 537.25% | -50.00% | |||
| Normalized Diluted EPS | 650.15% | -40.14% | |||
| Average Basic Shares Outstanding | 0.46% | 0.35% | |||
| Average Diluted Shares Outstanding | -0.41% | 2.34% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||